Distillate Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Sell |
57,994
-4,653
| -7% | -$1.81M | 1.21% | 22 |
|
|
2025
Q1 | $27.2M | Sell |
62,647
-17,314
| -22% | -$7.53M | 1.4% | 11 |
|
|
2024
Q4 | $29.5M | Sell |
79,961
-41,241
| -34% | -$15.2M | 1.45% | 11 |
|
|
2024
Q3 | $63M | Buy |
121,202
+67,195
| +124% | +$34.9M | 3.16% | 5 |
|
|
2024
Q2 | $29.3M | Buy |
54,007
+53,980
| +199,926% | +$29.2M | 1.55% | 11 |
|
|
2024
Q1 | $14K | Hold |
27
| – | – | 2.35% | 24 |
|
|
2023
Q4 | $12.7K | Hold |
27
| – | – | 2.77% | 22 |
|
|
2023
Q3 | $11.8K | Buy |
27
+4
| +17% | +$1.74K | 2.97% | 30 |
|
|
2023
Q2 | $10.2K | Buy |
+23
| New | +$10.2K | 3.31% | 21 |
|
|
2022
Q4 | – | Sell |
-19,077
| Closed | -$8.64M | – | 119 |
|
|
2022
Q3 | $8.64M | Sell |
19,077
-2,535
| -12% | -$1.15M | 1.16% | 17 |
|
|
2022
Q2 | $10.4M | Buy |
21,612
+2,237
| +12% | +$1.08M | 1.49% | 14 |
|
|
2022
Q1 | $9.52M | Buy |
19,375
+1,444
| +8% | +$709K | 1.35% | 16 |
|
|
2021
Q4 | $8.31M | Buy |
17,931
+5,470
| +44% | +$2.54M | 1.39% | 15 |
|
|
2021
Q3 | $4.65M | Buy |
+12,461
| New | +$4.65M | 1.24% | 18 |
|
|
2021
Q2 | – | Sell |
-11,017
| Closed | -$3.96M | – | 124 |
|
|
2021
Q1 | $3.96M | Buy |
11,017
+2,024
| +23% | +$727K | 1.28% | 15 |
|
|
2020
Q4 | $2.82M | Buy |
+8,993
| New | +$2.82M | 1.35% | 12 |
|